Susquehanna International Group’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 6856 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 6810 |
|
|
2024
Q4 | – | Sell |
-1,259
| Closed | -$9.74K | – | 6546 |
|
|
2024
Q3 | $9.74K | Sell |
1,259
-27,713
| -96% | -$214K | ﹤0.01% | 5469 |
|
|
2024
Q2 | $174K | Buy |
28,972
+23,640
| +443% | +$142K | ﹤0.01% | 4836 |
|
|
2024
Q1 | $48.1K | Sell |
5,332
-3,209
| -38% | -$28.9K | ﹤0.01% | 5182 |
|
|
2023
Q4 | $80.9K | Buy |
8,541
+2,959
| +53% | +$28K | ﹤0.01% | 5415 |
|
|
2023
Q3 | $66.4K | Sell |
5,582
-2,189
| -28% | -$26.1K | ﹤0.01% | 5037 |
|
|
2023
Q2 | $190K | Sell |
7,771
-10,501
| -57% | -$257K | ﹤0.01% | 4674 |
|
|
2023
Q1 | $572K | Buy |
18,272
+14,730
| +416% | +$461K | ﹤0.01% | 3639 |
|
|
2022
Q4 | $249K | Sell |
3,542
-5,720
| -62% | -$403K | ﹤0.01% | 4157 |
|
|
2022
Q3 | $797K | Sell |
9,262
-1,830
| -16% | -$157K | ﹤0.01% | 2859 |
|
|
2022
Q2 | $917K | Buy |
11,092
+4,491
| +68% | +$371K | ﹤0.01% | 2550 |
|
|
2022
Q1 | $1.1M | Buy |
6,601
+1,323
| +25% | +$220K | ﹤0.01% | 2692 |
|
|
2021
Q4 | $882K | Buy |
+5,278
| New | +$882K | ﹤0.01% | 3019 |
|
|
2021
Q2 | – | Sell |
-3,040
| Closed | -$181K | – | 5662 |
|
|
2021
Q1 | $181K | Buy |
3,040
+1,527
| +101% | +$90.9K | ﹤0.01% | 4829 |
|
|
2020
Q4 | $79K | Sell |
1,513
-144
| -9% | -$7.52K | ﹤0.01% | 4540 |
|
|
2020
Q3 | $80K | Buy |
+1,657
| New | +$80K | ﹤0.01% | 4151 |
|
|
2020
Q2 | – | Sell |
-1,134
| Closed | -$49K | – | 4602 |
|
|
2020
Q1 | $49K | Buy |
+1,134
| New | +$49K | ﹤0.01% | 4218 |
|